Skip to content

Clinical trials

Recruiting Phase 3 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 3 Status: Recruiting Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20221
20232
20241
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S2
Sanofi2
Agios Pharmaceuticals, Inc.1
Assistance Publique - Hôpitaux de Paris1
Brown University1
King's College Hospital NHS Trust1
Nantes University Hospital1
Novartis Pharmaceuticals1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell11
Acute Chest Syndrome2
Hematologic Diseases2
Thalassemia2
Vaso-Occlusive Crises2
Agnosia1
Genetic Diseases, Inborn1
Hemoglobinopathies1
Sickle Cell Trait1
beta-Thalassemia1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.